Home > Insider Trading > Filing (0001209191-17-040615)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1569002	B Steven Ruchefsky	C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-14	20,000	$89.48	205,426	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The reporting person's sale of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,400 shares, with the reporting person's purchase of 1,400 shares of the Issuer's common stock at a price of $69.50 per share on May 9, 2017. The reporting person has agreed to pay to the Issuer, upon settlement of the trade, $28,945 representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.25 to $90.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.